{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:12:22Z","timestamp":1793261542526,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","award":["19\/25225"],"award-info":[{"award-number":["19\/25225"]}],"id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejvs.2023.11.037","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T12:23:18Z","timestamp":1700914998000},"page":"570-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Exploring Drug Re-Purposing for Treatment of Abdominal Aortic Aneurysms: a Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-0153","authenticated-orcid":false,"given":"Joachim S.","family":"Skovbo Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-9779","authenticated-orcid":false,"given":"Lytfi","family":"Krasniqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-8962","authenticated-orcid":false,"given":"Lasse M.","family":"Obel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Kavaliunaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5275-4176","authenticated-orcid":false,"given":"Mads","family":"Liisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9536-4488","authenticated-orcid":false,"given":"Jes S.","family":"Lindholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2023.11.037_bib1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2023.11.037_bib2","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1161\/CIR.0000000000001106","article-title":"2022 ACC\/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"146","author":"Isselbacher","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2023.11.037_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejvs.2023.11.037_bib5","first-page":"CD009536","article-title":"Medical treatment for small abdominal aortic aneurysms","volume":"9","author":"Rughani","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejvs.2023.11.037_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/heartjnl-2018-314639","article-title":"Metformin prescription and aortic aneurysm: systematic review and meta-analysis","volume":"105","author":"Yu","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.ejvs.2023.11.037_bib7","article-title":"Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis","volume":"7","author":"Salata","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2023.11.037_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ejvs.2021.06.013","article-title":"Editor\u2019s Choice \u2013 Association between metformin prescription and abdominal aortic aneurysm growth and clinical events: a systematic review and meta-analysis","volume":"62","author":"Thanigaimani","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/heartjnl-2020-318192","article-title":"Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis","volume":"107","author":"Golledge","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.ejvs.2023.11.037_bib10","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2023.11.037_bib11","author":"Sejr Skovbo Kristensen"},{"key":"10.1016\/j.ejvs.2023.11.037_bib13","series-title":"Covidence Systematic Review Software","year":"2023"},{"key":"10.1016\/j.ejvs.2023.11.037_bib14","article-title":"Data from exploring drug repurposing for the treatment of abdominal aortic aneurysms: a systematic review and meta-analysis","volume":"V1","author":"Kristensen","year":"2023","journal-title":"Mendeley Data"},{"key":"10.1016\/j.ejvs.2023.11.037_bib15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2023.11.037_bib16","author":"Wells"},{"key":"10.1016\/j.ejvs.2023.11.037_bib17","author":"Higgins"},{"key":"10.1016\/j.ejvs.2023.11.037_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejvs.2023.11.037_bib19","author":"Sch\u00fcnemann"},{"key":"10.1016\/j.ejvs.2023.11.037_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/bjs.11135","article-title":"Baseline findings of the population-based, randomized, multifaceted Danish Cardiovascular Screening trial (DANCAVAS) of men aged 65\u201374 years","volume":"106","author":"Lindholt","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib21","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0140-6736(17)32250-X","article-title":"Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial","volume":"390","author":"Lindholt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2023.11.037_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa2208681","article-title":"Five-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial","volume":"387","author":"Lindholt","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2023.11.037_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jvs.2016.02.020","article-title":"Metformin treatment status and abdominal aortic aneurysm disease progression","volume":"64","author":"Fujimura","year":"2016","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jvs.2017.01.070","article-title":"Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms","volume":"66","author":"Kristensen","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib25","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/bjs.10587","article-title":"Association between metformin prescription and growth rates of abdominal aortic aneurysms","volume":"104","author":"Golledge","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jvs.2018.06.194","article-title":"Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population","volume":"69","author":"Itoga","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejvs.2018.07.035","article-title":"Editor\u2019s Choice \u2013 Metformin prescription is associated with a reduction in the combined incidence of surgical repair and rupture related mortality in patients with abdominal aortic aneurysm","volume":"57","author":"Golledge","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/jim-2019-001177","article-title":"Association between metformin and abdominal aortic aneurysm in diabetic and non-diabetic US veterans","volume":"68","author":"Sutton","year":"2020","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.ejvs.2023.11.037_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin prescription associated with reduced abdominal aortic aneurysm growth rate and reduced chemokine expression in a Swedish cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jvs.2010.02.012","article-title":"An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance","volume":"52","author":"Thompson","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib31","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/biomedicines10092112","article-title":"Association of oral anticoagulation prescription with clinical events in patients with an asymptomatic unrepaired abdominal aortic aneurysm","volume":"10","author":"Golledge","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejvs.2023.11.037_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1538574408315205","article-title":"Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms","volume":"42","author":"Lindholt","year":"2008","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2310\/JIM.0b013e318297d0f9","article-title":"Long-term outcome of patients with aortic aneurysms taking low-dose aspirin: a population-based cohort study","volume":"61","author":"Chen","year":"2013","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.ejvs.2023.11.037_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jvs.2016.04.061","article-title":"Low-dose aspirin and rupture of abdominal aortic aneurysm","volume":"65","author":"Wemmelund","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib35","first-page":"450","article-title":"The effect of ticagrelor on growth of small abdominal aortic aneurysms\u2014a randomized controlled trial","volume":"116","author":"Wanhainen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejvs.2023.11.037_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/archsurg.1988.01400290092015","article-title":"Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms","volume":"123","author":"Leach","year":"1988","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0741-5214(02)00129-5","article-title":"Are antihypertensive drugs associated with abdominal aortic aneurysms?","volume":"36","author":"Wilmink","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0741-5214(94)70048-6","article-title":"Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade","volume":"19","author":"Gadowski","year":"1994","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib39","first-page":"52","article-title":"Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms","volume":"18","author":"Lindholt","year":"1999","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2023.11.037_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mva.2002.121308","article-title":"Propranolol for small abdominal aortic aneurysms: results of a randomized trial","volume":"35","author":"Laupacis","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ejvs.2019.12.039","article-title":"Pharmacological preventive potential among attenders at vascular screening: findings from the VIVA trial","volume":"59","author":"Hansen","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)69250-7","article-title":"Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case\u2013control study","volume":"368","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2023.11.037_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.02.264","article-title":"Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms","volume":"52","author":"Sweeting","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib44","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/ATVBAHA.114.304428","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study","volume":"35","author":"Kristensen","year":"2015","journal-title":"Arterioscl Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2023.11.037_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pds.3913","article-title":"Preadmission use of renin\u2013angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population-based study","volume":"25","author":"Wemmelund","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ejvs.2023.11.037_bib46","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehw257","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)","volume":"37","author":"Bicknell","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2023.11.037_bib47","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jamacardio.2020.3524","article-title":"Efficacy of telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial","volume":"5","author":"Golledge","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejvs.2023.11.037_bib48","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jvs.2008.01.041","article-title":"Growth predictors and prognosis of small abdominal aortic aneurysms","volume":"47","author":"Schlosser","year":"2008","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib49","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1510\/icvts.2008.178103","article-title":"The use of statins and fate of small abdominal aortic aneurysms","volume":"7","author":"Mosorin","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ahj.2009.11.016","article-title":"Association of statin prescription with small abdominal aortic aneurysm progression","volume":"159","author":"Ferguson","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejvs.2023.11.037_bib51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2310\/JIM.0b013e31823548e8","article-title":"Statin therapy reduces growth of abdominal aortic aneurysms","volume":"59","author":"Karrowni","year":"2011","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.ejvs.2023.11.037_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1024\/0301-1526\/a000161","article-title":"Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins","volume":"41","author":"Periard","year":"2012","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2023.11.037_bib53","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1253\/circj.CJ-16-0902","article-title":"Oral steroid use and abdominal aortic aneurysm expansion \u2013 positive association","volume":"81","author":"Tajima","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.ejvs.2023.11.037_bib54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mva.2001.117891","article-title":"Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study","volume":"34","author":"Mosorin","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib55","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2023.11.037_bib56","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.0007-1323.2001.01845.x","article-title":"Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion","volume":"88","author":"Vammen","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1538574409335037","article-title":"Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial","volume":"43","author":"Hogh","year":"2009","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jvs.2008.12.048","article-title":"The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms\u2014a prospective randomized double-blind trial","volume":"50","author":"Karlsson","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bcpt.13591","article-title":"Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: a case-crossover analysis","volume":"129","author":"Lawaetz Kristensen","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ejvs.2023.11.037_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.100.1.48","article-title":"Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms","volume":"100","author":"Walton","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2023.11.037_bib61","article-title":"Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME-2 trial","volume":"7","author":"Pinchbeck","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2023.11.037_bib62","author":"Yonsei"},{"key":"10.1016\/j.ejvs.2023.11.037_bib63","author":"RenJi"},{"key":"10.1016\/j.ejvs.2023.11.037_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejvs.2005.12.024","article-title":"Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth","volume":"32","author":"Schouten","year":"2006","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2023.11.037_bib65","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bjs.8707","article-title":"Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms","volume":"99","author":"Sweeting","year":"2012","journal-title":"Br J Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842300967X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107858842300967X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T22:44:02Z","timestamp":1712875442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107858842300967X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S107858842300967X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2023.11.037","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Drug Re-Purposing for Treatment of Abdominal Aortic Aneurysms: a Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2023.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}